CORCEPT THERAPEUTICS INC Accumulated Other Comprehensive Income
CORCEPT THERAPEUTICS INC (CORT) had Accumulated Other Comprehensive Income of $436.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-29
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $436.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $918.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.26M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.34M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $436.00K 10-Q · filed 2026-07-29 |
| 2026-03-31 | $918.00K 10-Q · filed 2026-04-30 |
| 2025-12-31 | $2.26M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $2.34M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $2.29M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $692.00K 10-Q · filed 2025-05-05 |
| 2024-12-31 | -$217.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.57M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $84.00K 10-Q · filed 2024-07-29 |
| 2024-03-31 | $258.00K 10-Q · filed 2024-05-01 |
| 2023-12-31 | $609.00K 10-K · filed 2025-02-26 |
| 2023-09-30 | -$234.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $45.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$153.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$869.00K 10-K · filed 2024-02-15 |
| 2022-09-30 | -$2.38M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$2.14M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$1.35M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$227.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $115.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $215.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $249.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $415.00K 10-K · filed 2022-02-15 |
| 2020-09-30 | $577.00K 10-Q · filed 2020-11-03 |
| 2020-06-30 | $840.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $310.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $261.00K 10-K · filed 2021-02-23 |
| 2019-09-30 | $314.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $321.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $94.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$70.00K 10-K · filed 2020-02-24 |
| 2018-09-30 | -$77.00K 10-Q · filed 2018-11-02 |
| 2018-06-30 | -$127.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$152.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$75.00K 10-K · filed 2019-02-26 |
| 2017-09-30 | -$14.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | -$17.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$12.00K 10-Q · filed 2017-05-02 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |